Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:140-148
Published online before print June 23, 2008, doi: 10.1161/CIRCULATIONAHA.107.737890
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/2/140    most recent
CIRCULATIONAHA.107.737890v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flögel, U.
Right arrow Articles by Schrader, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flögel, U.
Right arrow Articles by Schrader, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Other heart failure
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Animal models of human disease
Right arrow Imaging
Right arrow CT and MRI
Right arrow Acute Cerebral Infarction
Right arrowRelated Article

(Circulation. 2008;118:140-148.)
© 2008 American Heart Association, Inc.


Imaging

In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging

Ulrich Flögel, PhD; Zhaoping Ding, MD; Hendrik Hardung, PhG; Sebastian Jander, MD; Gaby Reichmann, PhD; Christoph Jacoby, PhD; Rolf Schubert, PhD; Jürgen Schrader, MD

From the Institut für Herz- und Kreislaufphysiologie (U.F., Z.D., C.J., J.S.) and Institut für Medizinische Mikrobiologie und Krankenhaushygiene (G.R.), Heinrich-Heine-Universität, Düsseldorf; Lehrstuhl für Pharmazeutische Technologie und Biopharmazie, Albert-Ludwigs-Universität Freiburg, Freiburg (H.H., R.S.); and Neurologische Klinik, Universitätsklinikum Düsseldorf, Düsseldorf (S.J.), Germany.

Correspondence to Ulrich Flögel, PhD, Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität, Postfach 101007, 40001 Düsseldorf, Germany. E-mail floegel{at}uni-duesseldorf.de

Received September 4, 2007; accepted April 28, 2008.

Background— In this study, we developed and validated a new approach for in vivo visualization of inflammatory processes by magnetic resonance imaging using biochemically inert nanoemulsions of perfluorocarbons (PFCs).

Methods and Results— Local inflammation was provoked in 2 separate murine models of acute cardiac and cerebral ischemia, followed by intravenous injection of PFCs. Simultaneous acquisition of morphologically matching proton (1H) and fluorine (19F) images enabled an exact anatomic localization of PFCs after application. Repetitive 1H/19F magnetic resonance imaging at 9.4 T revealed a time-dependent infiltration of injected PFCs into the border zone of infarcted areas in both injury models, and histology demonstrated a colocalization of PFCs with cells of the monocyte/macrophage system. We regularly found the accumulation of PFCs in lymph nodes. Using rhodamine-labeled PFCs, we identified circulating monocytes/macrophages as the main cell fraction taking up injected nanoparticles.

Conclusions— PFCs can serve as a "positive" contrast agent for the detection of inflammation by magnetic resonance imaging, permitting a spatial resolution close to the anatomic 1H image and an excellent degree of specificity resulting from the lack of any 19F background. Because PFCs are nontoxic, this approach may have a broad application in the imaging and diagnosis of numerous inflammatory disease states.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 105-106. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Saraste, S. G. Nekolla, and M. Schwaiger
Cardiovascular molecular imaging: an overview
Cardiovasc Res, September 1, 2009; 83(4): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1326 - 1337.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. A. Osborn and F. A. Jaffer
The year in molecular imaging.
J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 97 - 113.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler
Multimodality Cardiovascular Molecular Imaging, Part I
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 244 - 256.
[Full Text] [PDF]


Home page
CirculationHome page
J. Schwitter
Extending the Frontiers of Cardiac Magnetic Resonance
Circulation, July 8, 2008; 118(2): 109 - 112.
[Full Text] [PDF]